SCHEMBL218005

SCHEMBL218005

O=[C]NC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10486493 0.72
SCHEMBL62916 0.67
SCHEMBL10746548 0.67
SCHEMBL42913 0.67
SCHEMBL87986 0.67
SCHEMBL8906773 0.67
SCHEMBL11039486 0.67
Methane SCHEMBL8513662 0.65
SCHEMBL2967380 0.65
SCHEMBL3527203 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343987-B2 Heterocyclic derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-01-01 US claimed
US-8088927-B2 Fungicide N-cycloalkyl-benzyl-amide derivatives BAYER CROPSCIENCE AG (DE) 2012-01-03 US claimed
US-20110306646-A1 FUNGICIDAL N-(PHENYLCYCLOALKYL)CARBOXAMIDE, N-(BENZYLCYCLOALKYL)CARBOXAMIDE AND THIOCARBOXAMIDE DERIVATIVES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2011-12-15 US claimed
US-20100184788-A1 HETEROCYCLIC DERIVATIVES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-07-22 US claimed
US-20100022531-A1 NOVEL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF RENOVIS, INC. (US) 2010-01-28 US claimed
US-20090012060-A1 Antitumor Agent KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-01-08 US claimed
US-7208502-B2 Methods of treating conditions associated with an Edg-3 receptor MANIV ENERGY CAPITAL (US) 2007-04-24 US claimed
US-6596687-B1 For treatment of many inflammatory and autoimmune diseases BIOGEN, INC. 2003-07-22 US claimed
US-6583133-B1 Especially against Gram-positive organisms, e.g. methicillin-sensitive (MSSA) and methicillin- resistant (MRSA) staphylococci, enterococci and pneumococci BASILEA PHARMACEUTICA AG (CH) 2003-06-24 US claimed
EP-0772599-A1 2-IMIDAZOLIDINONE DERIVATIVES AS FUNGICIDES BAYER AG (DE) 1997-05-14 EP claimed
US-5008258-A Antibiotics I.C.I.-PHARMA (FR) 1991-04-16 US claimed
EP-0391077-A1 O56-alkyl derivatives of aglycone and pseudoaglycones of teicoplanin GRUPPO LEPETIT S.p.A. (IT) 1990-10-10 EP claimed
CN-1043939-A The method of the 63-carboxylic acid amide of preparation antibiotic teicoplanins LEPETIT SPA (IT) 1990-07-18 CN claimed
EP-0370283-A2 Process for preparing 63-carboxyamides of teicoplanin antibiotics GRUPPO LEPETIT S.p.A. (IT) 1990-05-30 EP claimed
EP-0341990-A2 Cephalosporins, process for their preparation and pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-11-15 EP claimed
EP-0330616-A1 Wettable, flexible, oxygen permeable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units, and use thereof CIBA-GEIGY AG (CH) 1989-08-30 EP claimed
EP-0304155-A2 Cephalosporin compounds, process for their preparation and their pharmaceutical compositions ZENECA Pharma S.A. (FR) 1989-02-22 EP claimed
EP-0304158-A1 Cephalosporins, processes for their preparation and pharmaceutical compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-02-22 EP claimed
EP-0300664-A2 Cephalosporin compounds ZENECA Pharma S.A. (FR) 1989-01-25 EP claimed
EP-0300665-A2 Cephalosporin compounds, process for their preparation and their pharmaceutical compositions ZENECA Pharma S.A. (FR) 1989-01-25 EP claimed